Stockscreener 앱 받기
13.09
4.24%
-0.58
시간 외 거래:
13.08
-0.010
-0.08%
전일 마감가:
$13.67
열려 있는:
$13.8
하루 거래량:
71,538
Relative Volume:
0.34
시가총액:
$490.10M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.75%
1개월 성능:
-2.24%
6개월 성능:
+14.82%
1년 성능:
+0.00%
1일 변동 폭
$12.89
$13.90
1주일 범위
$12.89
$15.68
52주 변동 폭
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
명칭
Oruka Therapeutics Inc
전화
650-606-7910
주소
855 OAK GROVE AVE., MENLO PARK
ORKA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
13.09 | 531.28M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-22 | 개시 | BTIG Research | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-10-11 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | H.C. Wainwright | Buy |
| 2024-09-17 | 개시 | Leerink Partners | Outperform |
| 2024-09-16 | 개시 | TD Cowen | Buy |
| 2024-09-13 | 개시 | Jefferies | Buy |
| 2018-02-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2013-10-09 | 개시 | Dawson James | Buy |
모두보기
Oruka Therapeutics Inc 주식(ORKA)의 최신 뉴스
Published on: 2025-08-10 17:56:29 - beatles.ru
RSI + MACD Show Convergence for Oruka Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it
How to build a custom watchlist for Oruka Therapeutics Inc.Buy Strategy with Smart Exit Timing - Newser
Published on: 2025-08-10 12:04:33 - metal.it
Has Oruka Therapeutics Inc. found a price floorReal Market Tracker with Price Action Tools - Newser
What Fibonacci levels say about Oruka Therapeutics Inc. reboundFree Daily Momentum Screener With Alerts - Newser
Long term hold vs stop loss in Oruka Therapeutics Inc.Short-Term Market Movement Forecast Report - Newser
Oruka Therapeutics Inc. Inches Above Key Support — Safe to HoldLow Risk High Return Opportunities Identified - metal.it
How Oruka Therapeutics Inc. stock performs during market volatilityFree Early Entry Tips With Low Risk Zone - Newser
Technical analysis overview for Oruka Therapeutics Inc. stockFree Breakout Momentum Picks With Protection - Newser
Published on: 2025-08-09 01:24:57 - Newser
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Smart tools for monitoring Oruka Therapeutics Inc.’s price actionBuy Opportunity Forecast for Fast Traders - Newser
How to integrate Oruka Therapeutics Inc. into portfolio analysis toolsEarnings Report Summary with Market Impact - Newser
Why Oruka Therapeutics Inc. stock attracts strong analyst attentionChart Risk Profile for Capital Preservation - Newser
What makes Oruka Therapeutics Inc. stock price move sharplyMomentum Detection with Entry Optimization - Newser
Can technical indicators confirm Oruka Therapeutics Inc.’s reversalWeekly Movement Forecast With Chart Signals - Newser
Custom watchlist performance reports with Oruka Therapeutics Inc.Short-Term Trade Setup with Forecast Insight - Newser
Oruka Therapeutics (ORKA) Expected to Announce Earnings on Thursday - Defense World
Oruka Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowFree Breakout Entry Signal Confirmation Tool - Newser
What data driven models say about Oruka Therapeutics Inc.’s futureMinimal Risk Growth Investment Opportunity Analysis - Newser
TD Cowen Maintains Oruka Therapeutics(ORKA.US) With Buy Rating - 富途牛牛
How high can Oruka Therapeutics Inc. stock price go in 2025Fundamental Analysis for Value Stock Selection - Newser
Is Oruka Therapeutics Inc. a good long term investmentFree Stock Selection - Jammu Links News
How strong is Oruka Therapeutics Inc. company’s balance sheetSky-high profits - Jammu Links News
How does Oruka Therapeutics Inc. generate profit in a changing economyIdentify winners with top-tier analysis - Jammu Links News
Is it the right time to buy Oruka Therapeutics Inc. stockAchieve triple-digit returns with smart investing - Jammu Links News
Why is Oruka Therapeutics Inc. stock attracting strong analyst attentionBuild a portfolio that grows with the market - Jammu Links News
What are the latest earnings results for Oruka Therapeutics Inc.Free Stock Market Beginners Guide - Jammu Links News
Is Oruka Therapeutics Inc. stock overvalued or undervaluedBuild a diversified portfolio for sustainable growth - Jammu Links News
How volatile is Oruka Therapeutics Inc. stock compared to the marketDiscover undervalued stocks ready to soar - Jammu Links News
What is Oruka Therapeutics Inc. company’s growth strategyUnlock steady growth with low-risk stocks - Jammu Links News
What are Oruka Therapeutics Inc. company’s key revenue driversConsistently exceptional gains - Jammu Links News
What analysts say about Oruka Therapeutics Inc. stockUnlock powerful investment tools for free - Jammu Links News
When is Oruka Therapeutics Inc. stock expected to show significant growthMaximize returns with smart investment plans - Jammu Links News
Does Oruka Therapeutics Inc. stock perform well during market downturnsHigh-yield capital appreciation - Jammu Links News
What drives Oruka Therapeutics Inc. stock priceBuild wealth faster with disciplined trading - Jammu Links News
What is the dividend policy of Oruka Therapeutics Inc. stockHigh-yield portfolio picks - Jammu Links News
How does Oruka Therapeutics Inc. compare to its industry peersPowerful market insights - Jammu Links News
Is Oruka Therapeutics Inc. a growth stock or a value stockGet professional advice for market timing - Jammu Links News
Real time scanner hits for Oruka Therapeutics Inc. explainedChart Risk Profile for Capital Preservation - Newser
Oruka Therapeutics Inc. Consolidation Zone May Signal AccumulationSector Based Breakout Stock Forecast Issued - metal.it
Oruka Therapeutics Inc (ORKA) 재무 분석
Oruka Therapeutics Inc (ORKA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):